Global Neurological Disorder Drugs Market Professional Survey Report 2017

January 2017 | 127 pages | ID: G695E062BCDEN
QYResearch

Abstracts

Notes:

Production, means the output of Neurological Disorder Drugs

Revenue, means the sales value of Neurological Disorder Drugs

This report studies Neurological Disorder Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Novartis AG
• GlaxoSmithKline plc
• Merck & Co.
• Bayer AG
• AstraZeneca
• Boehringer Ingelheim GmbH
• Teva Pharmaceutical Industries Ltd.
• F. Hoffmann-La Roche Ltd.

By types, the market can be split into

• Antipsychotic
• Hypnotic & Sedative
• Analgesics
• Anticoagulants
• Others

By Application, the market can be split into

• Hospital
• Clinic
• Home

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

Contents

Global Neurological Disorder Drugs Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF NEUROLOGICAL DISORDER DRUGS

1.1 Definition and Specifications of Neurological Disorder Drugs
  1.1.1 Definition of Neurological Disorder Drugs
  1.1.2 Specifications of Neurological Disorder Drugs
1.2 Classification of Neurological Disorder Drugs
  1.2.1 Antipsychotic
  1.2.2 Hypnotic & Sedative
  1.2.3 Analgesics
  1.2.4 Anticoagulants
  1.2.5 Others
1.3 Applications of Neurological Disorder Drugs
  1.3.1 Hospital
  1.3.2 Clinic
  1.3.3 Home
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF NEUROLOGICAL DISORDER DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Neurological Disorder Drugs
2.3 Manufacturing Process Analysis of Neurological Disorder Drugs
2.4 Industry Chain Structure of Neurological Disorder Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF NEUROLOGICAL DISORDER DRUGS

3.1 Capacity and Commercial Production Date of Global Neurological Disorder Drugs Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Neurological Disorder Drugs Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Neurological Disorder Drugs Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Neurological Disorder Drugs Major Manufacturers in 2015

4 GLOBAL NEUROLOGICAL DISORDER DRUGS OVERALL MARKET OVERVIEW

4.1 2011-2016 Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2011-2016 Global Neurological Disorder Drugs Capacity and Growth Rate Analysis
  4.2.2 2015 Neurological Disorder Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2016 Global Neurological Disorder Drugs Sales and Growth Rate Analysis
  4.3.2 2015 Neurological Disorder Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2016 Global Neurological Disorder Drugs Sales Price
  4.4.2 2015 Neurological Disorder Drugs Sales Price Analysis (Company Segment)

5 NEUROLOGICAL DISORDER DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Neurological Disorder Drugs Market Analysis
  5.1.1 North America Neurological Disorder Drugs Market Overview
  5.1.2 North America 2011-2016 Neurological Disorder Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2011-2016 Neurological Disorder Drugs Sales Price Analysis
  5.1.4 North America 2015 Neurological Disorder Drugs Market Share Analysis
5.2 China Neurological Disorder Drugs Market Analysis
  5.2.1 China Neurological Disorder Drugs Market Overview
  5.2.2 China 2011-2016 Neurological Disorder Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2011-2016 Neurological Disorder Drugs Sales Price Analysis
  5.2.4 China 2015 Neurological Disorder Drugs Market Share Analysis
5.3 Europe Neurological Disorder Drugs Market Analysis
  5.3.1 Europe Neurological Disorder Drugs Market Overview
  5.3.2 Europe 2011-2016 Neurological Disorder Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2011-2016 Neurological Disorder Drugs Sales Price Analysis
  5.3.4 Europe 2015 Neurological Disorder Drugs Market Share Analysis
5.4 Southeast Asia Neurological Disorder Drugs Market Analysis
  5.4.1 Southeast Asia Neurological Disorder Drugs Market Overview
  5.4.2 Southeast Asia 2011-2016 Neurological Disorder Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2011-2016 Neurological Disorder Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2015 Neurological Disorder Drugs Market Share Analysis
5.5 Japan Neurological Disorder Drugs Market Analysis
  5.5.1 Japan Neurological Disorder Drugs Market Overview
  5.5.2 Japan 2011-2016 Neurological Disorder Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2011-2016 Neurological Disorder Drugs Sales Price Analysis
  5.5.4 Japan 2015 Neurological Disorder Drugs Market Share Analysis
5.6 India Neurological Disorder Drugs Market Analysis
  5.6.1 India Neurological Disorder Drugs Market Overview
  5.6.2 India 2011-2016 Neurological Disorder Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2011-2016 Neurological Disorder Drugs Sales Price Analysis
  5.6.4 India 2015 Neurological Disorder Drugs Market Share Analysis

6 GLOBAL 2011-2016 NEUROLOGICAL DISORDER DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016 Neurological Disorder Drugs Sales by Type
6.2 Different Types of Neurological Disorder Drugs Product Interview Price Analysis
6.3 Different Types of Neurological Disorder Drugs Product Driving Factors Analysis
  6.3.1 Antipsychotic of Neurological Disorder Drugs Growth Driving Factor Analysis
  6.3.2 Hypnotic & Sedative of Neurological Disorder Drugs Growth Driving Factor Analysis
  6.3.3 Analgesics of Neurological Disorder Drugs Growth Driving Factor Analysis
  6.3.4 Anticoagulants of Neurological Disorder Drugs Growth Driving Factor Analysis
  6.3.5 Others of Neurological Disorder Drugs Growth Driving Factor Analysis

7 GLOBAL 2011-2016 NEUROLOGICAL DISORDER DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016 Neurological Disorder Drugs Consumption by Application
7.2 Different Application of Neurological Disorder Drugs Product Interview Price Analysis
7.3 Different Application of Neurological Disorder Drugs Product Driving Factors Analysis
  7.3.1 Hospital of Neurological Disorder Drugs Growth Driving Factor Analysis
  7.3.2 Clinic of Neurological Disorder Drugs Growth Driving Factor Analysis
  7.3.3 Home of Neurological Disorder Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF NEUROLOGICAL DISORDER DRUGS

8.1 Novartis AG
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Antipsychotic
    8.1.2.2 Hypnotic & Sedative
    8.1.2.3 Analgesics
  8.1.3 Novartis AG 2015 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Novartis AG 2015 Neurological Disorder Drugs Business Region Distribution Analysis
8.2 GlaxoSmithKline plc
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Antipsychotic
    8.2.2.2 Hypnotic & Sedative
    8.2.2.3 Analgesics
  8.2.3 GlaxoSmithKline plc 2015 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 GlaxoSmithKline plc 2015 Neurological Disorder Drugs Business Region Distribution Analysis
8.3 Merck & Co.
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Antipsychotic
    8.3.2.2 Hypnotic & Sedative
    8.3.2.3 Analgesics
  8.3.3 Merck & Co. 2015 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Merck & Co. 2015 Neurological Disorder Drugs Business Region Distribution Analysis
8.4 Bayer AG
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Antipsychotic
    8.4.2.2 Hypnotic & Sedative
    8.4.2.3 Analgesics
  8.4.3 Bayer AG 2015 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Bayer AG 2015 Neurological Disorder Drugs Business Region Distribution Analysis
8.5 AstraZeneca
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Antipsychotic
    8.5.2.2 Hypnotic & Sedative
    8.5.2.3 Analgesics
  8.5.3 AstraZeneca 2015 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 AstraZeneca 2015 Neurological Disorder Drugs Business Region Distribution Analysis
8.6 Boehringer Ingelheim GmbH
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Antipsychotic
    8.6.2.2 Hypnotic & Sedative
    8.6.2.3 Analgesics
  8.6.3 Boehringer Ingelheim GmbH 2015 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Boehringer Ingelheim GmbH 2015 Neurological Disorder Drugs Business Region Distribution Analysis
8.7 Teva Pharmaceutical Industries Ltd.
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Antipsychotic
    8.7.2.2 Hypnotic & Sedative
    8.7.2.3 Analgesics
  8.7.3 Teva Pharmaceutical Industries Ltd. 2015 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Teva Pharmaceutical Industries Ltd. 2015 Neurological Disorder Drugs Business Region Distribution Analysis
8.8 F. Hoffmann-La Roche Ltd.
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Antipsychotic
    8.8.2.2 Hypnotic & Sedative
    8.8.2.3 Analgesics
  8.8.3 F. Hoffmann-La Roche Ltd. 2015 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 F. Hoffmann-La Roche Ltd. 2015 Neurological Disorder Drugs Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF NEUROLOGICAL DISORDER DRUGS MARKET

9.1 Global Neurological Disorder Drugs Market Trend Analysis
  9.1.1 Global 2016-2021 Neurological Disorder Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Neurological Disorder Drugs Sales Price Forecast
9.2 Neurological Disorder Drugs Regional Market Trend
  9.2.1 North America 2016-2021 Neurological Disorder Drugs Consumption Forecast
  9.2.2 China 2016-2021 Neurological Disorder Drugs Consumption Forecast
  9.2.3 Europe 2016-2021 Neurological Disorder Drugs Consumption Forecast
  9.2.4 Southeast Asia 2016-2021 Neurological Disorder Drugs Consumption Forecast
  9.2.5 Japan 2016-2021 Neurological Disorder Drugs Consumption Forecast
  9.2.6 India 2016-2021 Neurological Disorder Drugs Consumption Forecast
9.3 Neurological Disorder Drugs Market Trend (Product Type)
9.4 Neurological Disorder Drugs Market Trend (Application)

10 NEUROLOGICAL DISORDER DRUGS MARKETING TYPE ANALYSIS

10.1 Neurological Disorder Drugs Regional Marketing Type Analysis
10.2 Neurological Disorder Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Neurological Disorder Drugs by Regions
10.4 Neurological Disorder Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF NEUROLOGICAL DISORDER DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…

12 CONCLUSION OF THE GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neurological Disorder Drugs
Table Product Specifications of Neurological Disorder Drugs
Table Classification of Neurological Disorder Drugs
Figure Global Production Market Share of Neurological Disorder Drugs by Type in 2015
Figure Antipsychotic Picture
Table Major Manufacturers of Antipsychotic
Figure Hypnotic & Sedative Picture
Table Major Manufacturers of Hypnotic & Sedative
Figure Analgesics Picture
Table Major Manufacturers of Analgesics
Figure Anticoagulants Picture
Table Major Manufacturers of Anticoagulants
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Neurological Disorder Drugs
Figure Global Consumption Volume Market Share of Neurological Disorder Drugs by Application in 2015
Figure Hospital Examples
Table Major Consumers of Hospital
Figure Clinic Examples
Table Major Consumers of Clinic
Figure Home Examples
Table Major Consumers of Home
Figure Market Share of Neurological Disorder Drugs by Regions
Figure North America Neurological Disorder Drugs Market Size (2011-2021)
Figure China Neurological Disorder Drugs Market Size (2011-2021)
Figure Europe Neurological Disorder Drugs Market Size (2011-2021)
Figure Southeast Asia Neurological Disorder Drugs Market Size (2011-2021)
Figure Japan Neurological Disorder Drugs Market Size (2011-2021)
Figure India Neurological Disorder Drugs Market Size (2011-2021)
Table Neurological Disorder Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Neurological Disorder Drugs in 2015
Figure Manufacturing Process Analysis of Neurological Disorder Drugs
Figure Industry Chain Structure of Neurological Disorder Drugs
Table Capacity and Commercial Production Date of Global Neurological Disorder Drugs Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Neurological Disorder Drugs Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Neurological Disorder Drugs Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Neurological Disorder Drugs Major Manufacturers in 2015
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Neurological Disorder Drugs 2011-2016
Figure Global 2011-2016 Neurological Disorder Drugs Market Size (Volume) and Growth Rate
Figure Global 2011-2016 Neurological Disorder Drugs Market Size (Value) and Growth Rate
Table 2011-2016 Global Neurological Disorder Drugs Capacity and Growth Rate
Table 2015 Global Neurological Disorder Drugs Capacity List (Company Segment)
Table 2011-2016 Global Neurological Disorder Drugs Sales and Growth Rate
Table 2015 Global Neurological Disorder Drugs Sales List (Company Segment)
Table 2011-2016 Global Neurological Disorder Drugs Sales Price
Table 2015 Global Neurological Disorder Drugs Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Neurological Disorder Drugs 2011-2016
Figure North America 2011-2016 Neurological Disorder Drugs Sales Price
Figure North America 2015 Neurological Disorder Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Neurological Disorder Drugs 2011-2016
Figure China 2011-2016 Neurological Disorder Drugs Sales Price
Figure China 2015 Neurological Disorder Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Neurological Disorder Drugs 2011-2016
Figure Europe 2011-2016 Neurological Disorder Drugs Sales Price
Figure Europe 2015 Neurological Disorder Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Neurological Disorder Drugs 2011-2016
Figure Southeast Asia 2011-2016 Neurological Disorder Drugs Sales Price
Figure Southeast Asia 2015 Neurological Disorder Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Neurological Disorder Drugs 2011-2016
Figure Japan 2011-2016 Neurological Disorder Drugs Sales Price
Figure Japan 2015 Neurological Disorder Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Neurological Disorder Drugs 2011-2016
Figure India 2011-2016 Neurological Disorder Drugs Sales Price
Figure India 2015 Neurological Disorder Drugs Sales Market Share
Table Global 2011-2016 Neurological Disorder Drugs Sales by Type
Table Different Types Neurological Disorder Drugs Product Interview Price
Table Global 2011-2016 Neurological Disorder Drugs Sales by Application
Table Different Application Neurological Disorder Drugs Product Interview Price
Table Novartis AG Information List
Table Antipsychotic Neurological Disorder Drugs Overview
Table Hypnotic & Sedative Neurological Disorder Drugs Overview
Table 2015 Novartis AG Neurological Disorder Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Novartis AG 2015 Neurological Disorder Drugs Business Region Distribution
Table GlaxoSmithKline plc Information List
Table Antipsychotic Neurological Disorder Drugs Overview
Table Hypnotic & Sedative Neurological Disorder Drugs Overview
Table 2015 GlaxoSmithKline plc Neurological Disorder Drugs Revenue, Sales, Ex-factory Price
Figure 2015 GlaxoSmithKline plc 2015 Neurological Disorder Drugs Business Region Distribution
Table Merck & Co. Information List
Table Antipsychotic Neurological Disorder Drugs Overview
Table Hypnotic & Sedative Neurological Disorder Drugs Overview
Table 2015 Merck & Co. Neurological Disorder Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Merck & Co. 2015 Neurological Disorder Drugs Business Region Distribution
Table Bayer AG Information List
Table Antipsychotic Neurological Disorder Drugs Overview
Table Hypnotic & Sedative Neurological Disorder Drugs Overview
Table 2015 Bayer AG Neurological Disorder Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Bayer AG 2015 Neurological Disorder Drugs Business Region Distribution
Table AstraZeneca Information List
Table Antipsychotic Neurological Disorder Drugs Overview
Table Hypnotic & Sedative Neurological Disorder Drugs Overview
Table 2015 AstraZeneca Neurological Disorder Drugs Revenue, Sales, Ex-factory Price
Figure 2015 AstraZeneca 2015 Neurological Disorder Drugs Business Region Distribution
Table Boehringer Ingelheim GmbH Information List
Table Antipsychotic Neurological Disorder Drugs Overview
Table Hypnotic & Sedative Neurological Disorder Drugs Overview
Table 2015 Boehringer Ingelheim GmbH Neurological Disorder Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Boehringer Ingelheim GmbH 2015 Neurological Disorder Drugs Business Region Distribution
Table Teva Pharmaceutical Industries Ltd. Information List
Table Antipsychotic Neurological Disorder Drugs Overview
Table Hypnotic & Sedative Neurological Disorder Drugs Overview
Table 2015 Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Teva Pharmaceutical Industries Ltd. 2015 Neurological Disorder Drugs Business Region Distribution
Table F. Hoffmann-La Roche Ltd. Information List
Table Antipsychotic Neurological Disorder Drugs Overview
Table Hypnotic & Sedative Neurological Disorder Drugs Overview
Table 2015 F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Revenue, Sales, Ex-factory Price
Figure 2015 F. Hoffmann-La Roche Ltd. 2015 Neurological Disorder Drugs Business Region Distribution
Figure Global 2016-2021 Neurological Disorder Drugs Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Neurological Disorder Drugs Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Neurological Disorder Drugs Sales Price Forecast
Figure North America 2016-2021 Neurological Disorder Drugs Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Neurological Disorder Drugs Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Neurological Disorder Drugs Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Neurological Disorder Drugs Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Neurological Disorder Drugs Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Neurological Disorder Drugs Consumption Volume and Growth Rate Forecast
Table Global Sales Volume of Neurological Disorder Drugs by Types 2016-2021
Table Global Consumption Volume of Neurological Disorder Drugs by Applications 2016-2021
Table Traders or Distributors with Contact Information of Neurological Disorder Drugs by Regions